These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 699245

  • 1. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
    Curtiss C, Cohn JN, Vrobel T, Franciosa JA.
    Circulation; 1978 Nov; 58(5):763-70. PubMed ID: 699245
    [Abstract] [Full Text] [Related]

  • 2. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A, Kubo S, Hirota Y, Kawamura K, Takatsu T.
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [Abstract] [Full Text] [Related]

  • 3. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB, Cohn JN.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [Abstract] [Full Text] [Related]

  • 4. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP, Creager MA, Halperin JL, Bernard DB, Ryan TJ.
    Am J Med; 1984 May 31; 76(5B):104-10. PubMed ID: 6203405
    [Abstract] [Full Text] [Related]

  • 5. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ.
    Am J Cardiol; 1982 Nov 31; 50(5):967-72. PubMed ID: 6182786
    [Abstract] [Full Text] [Related]

  • 6. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
    Faxon DP, Creager MA, Halperin JL, Gavras H, Coffman JD, Ryan TJ.
    Circulation; 1980 May 31; 61(5):925-30. PubMed ID: 6153939
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP, Roberts AJ, Laragh JH.
    Am J Med; 1979 Nov 31; 67(5):785-91. PubMed ID: 315711
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN, Levine TB.
    Am J Cardiol; 1982 Apr 21; 49(6):1480-3. PubMed ID: 6176108
    [Abstract] [Full Text] [Related]

  • 9. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J, Cody RJ, Laragh JH.
    Am J Cardiol; 1982 May 21; 49(7):1667-74. PubMed ID: 7044087
    [Abstract] [Full Text] [Related]

  • 10. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K, Punzengruber C, Sinzinger H.
    Cardiology; 1983 May 21; 70(6):297-307. PubMed ID: 6370431
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ.
    Circulation; 1978 Nov 21; 58(5):770-6. PubMed ID: 699246
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M, Lee WH, Medina N, Yushak M.
    J Am Coll Cardiol; 1985 Sep 21; 6(3):635-45. PubMed ID: 2993397
    [Abstract] [Full Text] [Related]

  • 13. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA, Faxon DP, Weiner DA, Ryan TJ.
    Br Heart J; 1985 Apr 21; 53(4):431-5. PubMed ID: 3885981
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB, Olivari MT, Garberg V, Sharkey SW, Cohn JN.
    Circulation; 1984 Mar 21; 69(3):548-53. PubMed ID: 6319045
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M, Medina N, Yushak M.
    Am J Cardiol; 1984 Oct 01; 54(7):771-7. PubMed ID: 6091434
    [Abstract] [Full Text] [Related]

  • 16. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
    Mookherjee S, Obeid A, Warner R, Anderson G, Eich R, Smulyan H.
    Am J Cardiol; 1978 Dec 01; 42(6):987-92. PubMed ID: 727149
    [Abstract] [Full Text] [Related]

  • 17. Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.
    Tsutamoto T, Sakai H, Tanaka T, Fujii M, Yamamoto T, Wada A, Ohnishi M, Horie M.
    Circ J; 2007 Jun 01; 71(6):915-21. PubMed ID: 17526990
    [Abstract] [Full Text] [Related]

  • 18. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
    Resnick LM, Catanzaro D, Sealey JE, Laragh JH.
    Am J Hypertens; 2004 Mar 01; 17(3):203-8. PubMed ID: 15001191
    [Abstract] [Full Text] [Related]

  • 19. Improvement of chronic congestive heart-failure by oral captopril.
    Turini GA, Brunner HR, Gribic M, Waeber B, Gavras H.
    Lancet; 1979 Jun 09; 1(8128):1213-5. PubMed ID: 87679
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S, Nishioka A, Nishimura H, Sonotani N, Takatsu T.
    Jpn Circ J; 1980 Jun 09; 44(6):427-37. PubMed ID: 6995635
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.